The enzymes phosphohexose isomerase, lactate dehydrogenase, hydroxybutyrate dehydrogenase, isocitric dehydrogenase, glutamate dehydrogenase, and sorbital dehydrogenase were assayed in cases of known carcinoma of the cervix and of carcinoma in situ. Phosphohexose isomerase, lactate dehydrogenase, and isocitric dehydrogenase were also assayed in a number of normal women and in those with benign lesions. It is unlikely that vaginal fluid enzymology will provide a screening test for cervical carcinoma.
The success of exfoliative cytology in detecting preinvasive carcinoma of the cervix has stimulated research into more simply applied means of detecting this condition. The work of Odell and Burt (1950) , Fishman, Kasdon, and Homburger (1950) , and of Bonham and Gibbs (1962) , coupled with the rapid development of automated enzymological assays, suggested thepossibilityof using vaginal fluid enzyme levels. Most of the reports until now have not shown that any one enzyme fulfilled the requirements for either a screening or diagnostic technique. In this work the activities of phosphohexose isomerase (PHI), lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBD), glutamate dehydrogenase (GLDH), isocitrate dehydrogenase (ICD) , and sorbital dehydrogenase (SDH) in vaginal fluid have been studied. In the case of each enzyme there were reasons to merit its inclusion in the study.
Muir (1966) suggested that PHI might act as a screening test for cervical carcinoma, but in a survey using freeze drying in the preparation of the samples its activity did not prove reliable (Muir and Valteris, 1968) . Since it was shown that freeze drying caused considerable loss of PHI activity, the enzyme has been re-evaluated. Lactate dehydrogenase activity in the vaginal fluid has been shown to give similar results to that of 6-phosphogluconate dehydrogenase (Muir, 1966) . Latner (1964) and Latner, Turner, and Way (1966) showed that both in carcinoma in situ and invasive carcinoma there was a change in isoenzyme pattern towards the predominance of the slower moving isoenzymes. In this Received for publication 24 January 1969. 593 work the total LDH and the ratio of HBD/LDH have been studied as it was hoped that the latter might reduce the number of false positive results. Ayre and Goldberg (1966) found raised levels of ICD in carcinomatous cervical tissue. Glutamic dehydrogenase is a link enzyme between carbohydrate and amino acid metabolism, and in certain cases of leukaemia or cancer (Waisman, Monder, and Williams, 1956 ) raised serum levels have been found, and Rimbach and Bonow (1961) demonstrated raised serum sorbitol dehydrogenase activity in patients with uterine carcinoma.
MATERIALS AND METHODS
Samples were obtained from local well women's clinics, the hospital Gynaecological Outpatient Department, and the Radiotherapy Department.
Material was collected using the method of Bonham and Gibbs (1962) and samples were kept at -20°C until they were assayed. PREPARATION OF SAMPLE Nonidet P.40 was used to effect the release of enzymes from the vaginal fluid. A 10% concentration in water gave maximum enzyme release. Samples of vaginal fluid were mixed on a Rotamixer" until a homogeneously dispersed solution was obtained. Aliquots were pipetted into plastic centrifuge tubes, and equal aliquots of 10% nonidet added; the tubes were then mixed for a further five seconds. After 10 minutes' centrifugation at 10,000 g at 40C the supernatants or suitable dilutions were assayed for enzyme activity. Potassium estimations were made on a 1: 20 dilution of the supernatant. The Bell and Baron (1960) was used for assaying this enzyme, using 0-2 ml vaginal fluid supernatant instead of 0-2 ml serum.
SORBITOL DEHYDROGENASE (E.C.1.l1.14 L-IDIToL; NAD OXIDOREDUCTASE) The C. F. Boeringer test combination based on the assay of Gerlach and Schurmeyer (1960) was used. The vaginal supernatant was diluted to give a volume of 1 ml.
Boehringer test combination based on the assay of Gerlach (1957) was used. The vaginal supernatant was diluted to a volume of 1 ml for the assay.
CALCULATION OF RESULTS
The results of all the enzyme activities were obtained in mU/ml. The enzyme activity per millilitre was divided by potassium concentration per millilitre to give the enzyme activity per milliequivalent of vaginal fluid potassium. Since potassium is predominantly an intracellular electrolyte it has been used to relate the enzyme activity to the cellularity of the vaginal fluid debris (Labrum, Gibbs, and Stagg, 1967 samples from patients with carcinomatous and benign lesions using the ratio of HBD/LDH activities per unit of potassium (Table LII) .
ISOCITRATE DEHYDROGENASE Fifty-five of 63 samples of vaginal fluid obtained from women with gynaecological lesions had some ICD activity. One sample from patients with carcinoma of the cervix had no ICD activity (Table IV) . There was a considerable overlap of ICD activity in both benign and malignant lesions. Gibbs (1968) found a strong NADase activity in the vaginal fluid during his assay of 6-phosphogluconate dehydrogenase. The pH of the assays used was lower than the optimumpHforNADase activity. Gibbs found that nicotinamide and tryptophane inhibited the activity of this enzyme. Nicotinamide and tryptophane were added to the reaction mixture in a similar manner. In no samples could any evidence be found of an increased activity in the presence of these factors. This suggests that competing NADase activity was not responsible for the absence of GLDH or SDH activity in the vaginal fluid of patients with carcinoma of the cervix. carcinoma. Most of the ratios found in samples from patients with malignant lesions were in a similar range to those found in patients with benign lesions. As HBD is a measure of the fast moving isoenzyme components one could expect the HBD/ LDH ratio to be small in cases of carcinoma. As this was not the case, the present results would suggest that most of the activity of the enzymes found in vaginal fluid is derived from an inflammatory response of the tissues to the carcinoma. This has previously been suggested by Muir and Canti (1966) and by Churchouse, Carter, and Bonham (1967) . Since carcinoma in situ exfoliates fewer cells (Wied, Legoretta, Mohr, and Rauzy, 1962) (1950) and Odell and Burt (1950) on the beta glucuronidase activity in vaginal fluid and the subsequent studies stimulated much interest in this field. Over the past years a number of enzymes have been studied. These have included 6-phosphogluconate dehydrogenase, glucose-6-phosphate dehydrogenase, aldolase, glutamicoxaloacetictransaminase, andalphamonosidase. All these enzymes have shown high false positive rates, frequent false negative results in carcinoma in situ, and occasional false negative results in invasive carcinoma.
It seems unlikely that much progress can be made in this field until the nature of carcinoma in situ is better understood. When the relationship between enzyme-positive carcinoma in situ and invasive carcinoma is understood, vaginal fluid enzymology may be able to offer an automated screening technique. It seems unlikely that vaginal fluid enzymology will ever provide a specific test for carcinoma of the cervix.
